Table 1.
Characteristics of Patients and Tumors
| Median age at diagnosis of advanced disease (median, range) | 64.3 (57.9–68.9) |
| Gender (%) | |
| Female | 12 (57.1) |
| Male | 9 (42.9) |
| Disease stage (%) | |
| Locally advanced (unresectable) | 3 (14.3) |
| Metastatic | 18 (85.7) |
| Prior surgical resection (%) | 8 (38.1) |
| Median CA 19–9 levels in kU/l (range) | 481.5 (59.4–3355.0) |
| CA 19–9 levels (%) | |
| Within normal range | 3 (14.3) |
| Above normal range | 18 (85.7) |
| Site of metastatic disease (%) | |
| Liver | 11 (52.4) |
| Peritoneum | 5 (23.8) |
| Lung | 4 (19.0) |
| Other | 1 (4.8) |
| Number of metastatic sites (%) | |
| 0 | 3 (14.3) |
| 1 | 14 (66.7) |
| 2 | 2 (9.5) |
| ≥3 | 2 (9.5) |
| ECOG Performance Status (%) | |
| 0 | 17 (81) |
| 1 | 4 (19) |
Abbreviations: CA-19-9, carbohydrate antigen 19–9; ECOG, Eastern Cooperative Oncology Group.